Solid Tumor
Oncology·MeSH: Triple Negative Breast Neoplasms
850 drugs in development·253 companies·79 clinical trials
Drug Pipeline by Phase
Approved(6)
Phase 3(117)
Phase 2(109)
Phase 1(361)
Preclinical(93)
Unknown(11)
BLA Filed(1)
| Drug | Company |
|---|---|
| larotrectinib | LOXO ONCOLOGY, INC. (LOXO) |
Phase 1/Phase 2(130)
Phase 2/Phase 3(9)
Phase 4(13)
Compare drugs
Frequently asked questions
How many drugs are in development for Solid Tumor?
BioSniper tracks 850 drugs in development for Solid Tumor across 253 companies.
How many clinical trials target Solid Tumor?
There are 79 clinical trials targeting Solid Tumor tracked by BioSniper.
Deep-dive into Solid Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis